Lu, Xue-Li <br/><br/>
iRhom2 is involved in lipopolysaccharide-induced cardiac injury in vivo and in vitro through regulating inflammation response.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Feb 2017 
 - 645-653 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2016.11.075  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carrier Proteins--genetics<br/>Heart Injuries--chemically induced<br/>Inflammation--genetics<br/>Interleukin-18--genetics<br/>Interleukin-1beta--genetics<br/>Interleukin-6--genetics<br/>Lipopolysaccharides--pharmacology<br/>Male<br/>Mice, Inbred C57BL<br/>NF-kappa B--genetics<br/>Signal Transduction--genetics<br/>Toll-Like Receptor 4--genetics<br/>Tumor Necrosis Factor-alpha--genetics<br/>Up-Regulation--genetics